Ashley Shepherd shares her story of surviving an episode of sudden cardiac arrest, receiving an ICD, and later becoming a technical service specialist with St. Jude Medical.| Read More
CapSureFix Novus™ MRI SureScan ® 5076 Pacing Lead Approved for MR-Conditional Use in Patients with Slow Heartbeat Medtronic announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus™ MRI SureScan® 5076 Lead for use with magnetic resonance imaging (MRI). The lead is approved for MRI scans positioned on any region of the body when paired with a Medtronic dual-chamber MR-conditional pacemaker.| Full Article
Genetic Causes of Atrial Fibrillation to be Explored by Experts from Around the World as Part of $6 Million Award from the Leducq Foundation
The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a $6 million award from the Leducq Foundation. The Transatlantic Network of Excellence is made up of a team of researchers from around the world tasked with conducting first of its kind research on the genetic causes of atrial fibrillation (AF). The Institute will serve as the coordinating site in the United States (U.S.) and Amsterdam Medical Center will serve as the coordinating site for Europe. The Network will provide a platform for conducting cutting-edge and meaningful research into this common arrhythmia.| Full Article
AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), announced enrollment in the ABLATE Post Approval Study (PAS) is complete.
As of October 3, 2014, the ABLATE PAS enrolled 365 patients at 40 hospitals across the United States. AtriCure expects to release preliminary data from the study in about a year, with a complete report expected to be published in three years.
The ABLATE PAS evaluates clinical outcomes in patients with non-paroxysmal (persistent or longstanding persistent) forms of atrial fibrillation who were treated utilizing the AtriCure Synergy Ablation System to perform the Maze IV procedure. The non-paroxysmal Afib patient group represents about half of the diagnosed patient population and who are extremely challenging to manage with conventional medical therapy or catheter ablation.| Full Article
Comprehensive Clinical Data from Randomized Trials Reviewed| Full Article
IMAGES FROM EPLD
FROM THE CURRENT ISSUEView More
Stroke Coordinator Susan Maynard, MS, RN-BC, CCNS, CCRN-CMC describes the process Mount Nittany Medical Center underwent to achieve Primary Stroke Center certification.continue reading
This month we check out an EP program in Seoul, South Korea.continue reading
Archana Kodali, MD and Koroush Khalighi, MD, FAOP, FACC, FCCP describe the association of superior vena cava syndrome with an intracardiac device and antiphospholipid antibodies.continue reading
Texas Health Heart & Vascular Hospital Arlington, located on the campus of Texas Health Arlington Memorial Hospital, recently earned full Atrial Fibrillation Certification status from the Society of Cardiovascular Patient Care.continue reading
Kenneth Yamamura, MD, FACC and Bonnie McDonald RN, CEPS, RCIS from the Pepin Heart Institute present a case on persistent left superior vena cava.continue reading